• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 NEUROVA PHENOM CATHETER; CATHETER, PERCUTANEOUS, NEUROVASCULATURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 NEUROVA PHENOM CATHETER; CATHETER, PERCUTANEOUS, NEUROVASCULATURE Back to Search Results
Model Number FG13160-0615-1S
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thromboembolism (2654)
Date of Event 12/31/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A2.Only patient's birth year was reported to medtronic.Therefore, only the year of the reported birthdate is valid.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Medtronic received a report that there was distal embolization in the same territory during procedure, caused by fragmentation of the cloth during thrombectomy.The event resulted in hospitalization and had a causal relationship to the stent and procedure.Additional information received reported that the embolism was in the cerebral artery.Additional information received indicated the cause of the clot fragmentation was the mechanical thrombectomy.The initial location of the clot being treated was the middle cerebral artery (mca) m2 segment.The patient vessel tortuosity and whether the device(s) were prepared per the instructions for use (ifu) was not collected in the clinical trial.No additional action was taken in order to resolve the event.Additional information received reported that the event recovered/resolved the same day on (b)(6) 2020.The event was assessed to be not related to the stent retriever.Additional information received reported the clinical event committee (cec) adjudicated assessment of this event with the conclusion the distal embolization event had a causal relationship to the study procedure and could possibly be related tothe solitaire device and/or phenom 21 microcatheter.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHENOM CATHETER
Common Device Name
CATHETER, PERCUTANEOUS, NEUROVASCULATURE
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3 NEUROVA
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3 NEUROVA
9775 toledo way
irvine CA 92618
Manufacturer Contact
justin ellis
9775 toledo way
irvine, CA 92618
7635265677
MDR Report Key23653423
Report Number2029214-2025-02497
Device Sequence Number4903654
Product Code QJP
UDI-Device Identifier00847536041844
UDI-Public(01)00847536041844(17)230630(10)JL20-054
Combination Product (Y/N)N
Initial Reporter CountrySP
PMA/510(K) Number
K151638
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/30/2023
Device Model NumberFG13160-0615-1S
Device Catalogue NumberFG13160-0615-1S
Device Lot NumberJL20-054
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/19/2025
Supplement Date Received by Manufacturer12/23/2025
Initial Report FDA Received Date11/25/2025
Supplement Report FDA Received Date12/30/2025
Date Device Manufactured07/30/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age89 YR
Patient SexFemale
Patient Weight85 KG
-
-